PORTLAND, Ore., Jan. 31, 2026 /PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for...
Hence then, the article about trace biosciences announces fda ind clearance for first nerve specific imaging agent was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent )
Also on site :
- Costco’s $25 Glassware Set Is Giving Anthropologie Vibes for Less
- '90s Grunge Rock Band's Hits Revived in Special Tribute Performance
- Pentagon wants killer AI without safeguards – Reuters